The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Veldhuijzen, Nienke J ^a   Braunstein, Sarah L ^b   Vyankandondera, Joseph ^c,d   Ingabire, Chantal ^c   Ntirushwa, Justin ^c   Kestelyn, Evelyne ^a,c   Tuijn, Coosje ^e   Wit, Ferdinand W ^a   Umutoni, Aline ^c   Uwineza, Mireille ^c   Crucitti, Tania ^f   van de Wijgert, Janneke H H M ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Projet Ubuzima   (Rwanda)

^d Belgium Technical Cooperation   (Rwanda)

^e ROYAL TROPICAL INSTITUTE   (Netherlands)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; RISK ASSESSMENT; RWANDA; WOMEN'S HEALTH; CLASSIFICATION; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RWANDA;

EID: 82455168257     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-333     Document Type: Article

References (36)

1. Aral SO, Holmes KK. The epidemiology of STIs and their social and behavioral determinants: industrialized and developing countries. Sexually transmitted Diseases 2008, 53-92. New York: McGraw-Hill, Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, 4.
2. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008, 43(4 Suppl):S5-25. S25 e21-41.
3. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202(12):1789-99. 10.1086/657321, 21067372.
4. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. Aids 2006, 20(18):2337-2344. 10.1097/01.aids.0000253361.63578.14, 17117020.
5. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis 2001, 28(3):125-130. 10.1097/00007435-200103000-00001, 11289192.
6. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010, 10(12):862-74. 10.1016/S1473-3099(10)70190-0, 21075056.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 2008, 10 Lyon, France: International Agency for Research on Cancer.
8. Braunstein SL, Ingabire CM, Kestelyn E, Uwizera AU, Mwamarangwe L, Ntirushwa J, Nash D, Veldhuijzen NJ, Nel A, Vyankandondera J, van de Wijgert JHHM. High HIV incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 2011, 38(5):384-94.
9. Stevens MP, Garland SM, Tabrizi SN. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods 2008, 147(2):290-296. 10.1016/j.jviromet.2007.09.018, 17996311.
10. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. Jama 2002, 287(16):2114-2119. 10.1001/jama.287.16.2114, 11966386.
11. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527. 10.1056/NEJMoa021641, 12571259.
12. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6(4):204. 10.1016/S1470-2045(05)70086-3, 15830458.
13. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009, 4:8. 10.1186/1750-9378-4-8, 2694995, 19486508.
14. Veldhuijzen NJ, Dhont N, Vyankandondera J, Gasarabwe A, Busasa R, Crucitti T, vdWijgert JHHM. Prevalence and concordance of HPV, HIV and HSV-2 in heterosexual couples in Kigali, Rwanda. Sex Transm Dis - Accepted for publication
15. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 2009, 199(12):1851-1861. 10.1086/599123, 2814215, 19435429.
16. del Amo J, Gonzalez C, Belda J, Fernandez E, Martinez R, Gomez I, Torres M, Saiz AG, Ortiz M. Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: differences by geographical origin. J Womens Health (Larchmt) 2009, 18(12):2057-2064.
17. Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K, Depuydt CE, Claeys P, Bogers JP, Temmerman M. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis 2010, 10:18. 10.1186/1471-2334-10-18, 2845133, 20102630.
18. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009, 4(1):52-56. 10.1097/COH.0b013e32831a7246, 2756707, 19339939.
19. Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Serwadda D, Wawer MJ, Shah KV, Gray R. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008, 17(6):1300-1307. 10.1158/1055-9965.EPI-07-2678, 3158656, 18559545.
20. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis 2009, 36(5):305-311. 10.1097/OLQ.0b013e318194eb76, 19295468.
21. Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH. HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. Aids 2010, 24(14):2289-2292. 10.1097/QAD.0b013e32833cbb71, 20613457.
22. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001, 184(6):682-690. 10.1086/323081, 11517428.
23. De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M. Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis 2003, 30(2):137-142. 10.1097/00007435-200302000-00009, 12567172.
24. Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009, 199(10):1514-1524. 10.1086/598220, 19392625.
25. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol 116(3):572-577.
26. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005, 162(7):668-675. 10.1093/aje/kwi262, 16120706.
27. Verhoeven V, Baay M, Weyler J, Avonts D, Lardon F, Van Royen P, Vermorken JB. Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour. Eur J Clin Microbiol Infect Dis 2004, 23(9):735-737.
28. Nielsen A, Iftner T, Munk C, Kjaer SK. Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis 2009, 36(10):609-615. 10.1097/OLQ.0b013e3181a96d0e, 2789348, 19955872.
29. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl 3):S3/52-61.
30. Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 2009, 11(4):435-442. 10.1016/j.micinf.2009.01.004, 19397882.
31. Loomis WP, Starnbach MN. T cell responses to Chlamydia trachomatis. Curr Opin Microbiol 2002, 5(1):87-91. 10.1016/S1369-5274(02)00291-6, 11834375.
32. Scott M, Stites DP, Moscicki AB. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol 1999, 6(5):751-755. 95767, 10473530.
33. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006, 24(Suppl 3):S3/42-51.
34. Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, van de Wijgert JH, Oliveira RL, Diaz RS. Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 2010, 21(2):105-109. 10.1258/ijsa.2009.008436, 2847515, 20089995.
35. Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005, 191(7):1129-1139. 10.1086/427777, 15747249.
36. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008, 168(2):123-137. 10.1093/aje/kwn036, 2878094, 18483125.